A study to assess the unmet medical needs associated with the use of basal insulin in patients with type 2 diabetes

FRECHTEL, GUSTAVO; FORTI, LUJAN; FAINGOLD, CRISTINA; PEREZ MANGUI, FEDERICO; ORIO, SILVIA; ISSA, CLAUDIA; GUAITA, MARÍA S.; VIVAS, NORMA; DE LUCA, JULIAN A.

Endocrinology, Diabetes and Metabolism

Blackwell Publishing Ltd

Año: 2021 vol. 4

Aim: To describe in a real-world setting, the proportion of patients with a symptomatic hypoglycaemic event and the proportion of individuals with type 2 diabetes, who newly or recently initiated with basal insulin, achieving individual or general HbA1c target. Materials and Method: DINAS-AR was a national prospective observational study to assess the unmet needs in patients with type 2 diabetes treated with basal insulin with or without oral antihyperglycaemic drugs and/or GLP-1 receptor agonist. The study was conducted at 19 hospitals. Results: A total of 385 uncontrolled patients (≥18 years) who recently initiated basal insulin or who initiated treatment within a year prior to study enrolment entered the study. Outcomes were follow-up incidence of hypoglycaemic events, change of HbA1C and achievement of HBA1c